DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tymazoline
Tymazoline
(CD-P-PH/PHO) Report Classification/Justifica
Alphabetical Listing of ATC Drugs & Codes
Use of Combinations Comprising Non-Sedating Antihistamines And
Ehealth DSI [Ehdsi V2.2.1] European Commission
Drugs, Poisons and Controlled Substances Act 1981
Diccionario Del Sistema De Clasificación Anatómica, Terapéutica, Química - ATC CATALOGO SECTORIAL DE PRODUCTOS FARMACEUTICOS
Medicines Regulations 1984 (SR 1984/143)
Decongestants, Antihistamines and Nasal Irrigation for Acute Sinusitis in Children (Review)
Consolidated Advisory Statement Requirements for Medicine Labels
Active Plug (B) Shell (C) Active Plug
Thermal Study of Four Irradiated Imidazoline Derivatives in Solid State
ATC Vet 2015 Atccode Atcdescription Atcdescriptionsi
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Atc Index 2010
View the PDF Document
(12) United States Patent (10) Patent No.: US 8,829,005 B2 Abelson Et Al
Medicines Amendment Regulations (No 2) 2015
Review of the Square Box Symbol Uses
Top View
Method and Composition for Increased Skin Concentration of Active Agents by Iontophoresis
Solutions Your Api Intermediates
Australian Statistics on Medicines 2009
WO 2010/141834 Al
Pharmaceutical Composition for Ophthalmic Use Comprising A
(12) Patent Application Publication (10) Pub. No.: US 2015/0024048A1 Hemmingsen Et Al
Summary of Product Characteristics 1. Name Of
Supplementary Information Molecules Repartition Into the Various Groups
Table of Drugs and Chemicals (FY12)
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Medicines Regulations 1984 (SR 1984/143)
Required Advisory Statements for Medicine Labels
(19) United States (12) Patent Application Publication (10) Pub
(12) United States Patent (10) Patent No.: US 7,026,360 B1 Fest0 (45) Date of Patent: Apr
International Classification of Procedures in Medicine
Medicines Amendment Regulations (No 2) 2015
Xylometazoline Hydrochloride)
Required Advisory Statements for Medicine Labels
ATC Code Title
Package Leaflet: Information for the Patient Fenylefrin Abcur 0.05 Mg/Ml